Search results
NeuroSense Announces First Quarter 2024 Business Update
WRBL Columbus· 58 minutes agoNeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing novel treatments for severe neurodegenerative diseases, today provides a business update. "We were honored to ...
Jindal Global University releases Handbook on rights of transgender & gender-diverse persons
Investing.com· 9 hours agoThe Handbook demystifies the Transgender Persons (...
FDA Establishes CDER Center for Clinical Trial Innovation (C3TI) | JD Supra
JD Supra· 1 day agoC3TI will serve as the central support hub for innovative approaches to clinical trials designed to improve the quality and efficiency of drug development and regulatory decision-making ...
Opinion: As stem cell biologists, we’re concerned a Utah law will lead to a boom in snake oil sales
The Salt Lake Tribune· 1 day agoThe Legislature thus endorsed the idea that the safety and effectiveness of medical products need...
Q1 2024 Pulmonx Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 hours agoSpecifically, our team has been focused in three areas. First, training physicians to hospitals that have the potential to be high performing Zephyr Valve centers, second, ...
Brendan Depa's sentencing to be continued in Flagler County at a later date
Daytona Beach News-Journal· 23 hours agoHammond Justice Center in Bunnell. Depa, 18, has pleaded no contest to the charge of aggravated...
What marijuana reclassification means for the United States - WTOP News
WTOP Washington· 1 day agoThe U.S. Drug Enforcement Administration is moving toward reclassifying marijuana as a less...
Alpha-9 Oncology Announces First Patient Dosed in Phase 1 Study of A9-3202 in Patients with Locally...
FOX 4 Kansas City· 3 hours agoAlpha-9 Oncology (Alpha-9), a clinical stage company developing radiopharmaceuticals for the treatment of cancer patients worldwide, announced today that the first participant ...
Teleflex Announces Multiple Clinical and Real-World Evidence Studies to Be Highlighted at the 2024...
Benzinga· 1 day agoHighlights include two head-to-head randomized clinical trials (RCT) data presentations of UroLift™ System vs. other modalities to treat benign prostatic hyperplasia (BPH) -Additional studies examine post-surgery
A spotlight on mental health during May
Mansfield News Journal via Yahoo News· 5 hours agoBranham-Fonne introduced Scott Basilone, who started Monday as the agency’s manager of clinical programs and services, and noted that Carey Vogt has been...
